title: HIV prevention: integrating biomedical and behevioral interventions.
abstract: Recommendations for HIV prevention in clinical care settings by an IAS-USA panel were recently published. They include recommendations on HIV testing, antiretroviral therapy initiation, risk-reduction counseling, and antiretroviral therapy adherence counseling for HIV-infected individuals. For individuals at risk for HIV infection, recommendations for preexposure prophylaxis, other risk-reduction strategies, adherence counseling, and postexposure prophylaxis are included. Many HIV-infected individuals in the United States are not fully engaged in HIV care and are not virologically suppressed, thus a crucial component of efforts to reduce HIV transmission is moving patients through the HIV care continuum. This article summarizes an IAS-USA continuing education webinar presented by Carlos del Rio, MD, in September 2014.
authors.affiliation: Emory University School of Medicine, Atlanta, GA, USA.
authors.forename: Carlos
authors.initials: C
authors.lastname: Del Rio
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D001521:Behavior Therapy; D003191:Comprehensive Health Care / Q000706:statistics & numerical data; D003376:Counseling / Q000706:statistics & numerical data; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D055118:Medication Adherence; D017410:Practice Guidelines as Topic; D014481:United States
chemical_list: D044966:Anti-Retroviral Agents